Still feeling joy from our 2023 Holiday Party. We're ready to drive #cancerresearch through innovation and collaboration in the quantitative sciences in 2024 and beyond!

Svitlana Tyekucheva, PhD leads statistical collaboration for PYTHIA, a phase II global trial evaluating #genomics & progression free survival for post-menopausal women with advanced #breastcancer whose disease progressed after hormone therapy: bit.ly/3S8E5Iq ETOP IBCSG Partners Foundation

Congratulations Sahand Hormoz on promotion to Associate Professor of Systems Biology, @HarvardMed/ Dana-Farber. The Hormoz lab aims to to control biological systems to understand life and cure disease. Learn more: Hormoz Lab

Want to annotate HLA/KIR genes and genotype them in a phased assembly? Try Immuannot, a new method from our group. It can identify novel alleles and reveal complex haplotype structures that short-read based methods may have troubles with. Available at github.com/YingZhou001/Im…

We are hiring a Director of Training & Education to help us develop curricula & training sessions for our staff scientists and collaborators. It is a fully funded position and includes a dependent lecturer appointment at the Harvard T.H. Chan School of Public Health. Details here: ds.dfci.harvard.edu/wp-content/upl…

Congrats to Rafael Irizarry, Chair of Dana-Farber Data Science, on being named Lavine Family Chair for Preventative #Cancer Therapies at Dana-Farber!

This @harvardbiostats award honors the legendary Dr. Marvin Zelen, who founded our department in 1977! Nominations accepted through Fri, Feb 16: hsph.me/zelenaward. For an extra peek at the history of #statistics at Dana-Farber, check out ds.dfci.harvard.edu/about-us/.

Tomorrow, Tue Feb 6 at 1pm ET: Join our monthly Frontiers in #Biostatistics seminar led by Donna Spiegelman, ScD (Yale Biostatistics). Topic - "Quantitative Methods in Implementation Research: Concepts, Goals and Applications." Zoom link: bit.ly/FIBFeb24

In the last five years, Dana-Farber has played a foundational role in more than half the cancer drugs approved by the FDA. Dana-Farber’s revolutionary discoveries are changing cancer treatment everywhere. #DanaFarber #CancerTreatment

Announcing #Zelen2024! Join our annual symposium promoting #datascience in the public sphere. Health Disparities & #Cancer Fri Apr 5 1-5:30PM ET Free registration: bit.ly/zelen24 Speakers: Ade Adamson, MD MPP Cynthia Dwork Nate F Carmen E. Guerra Jinani_Jay Bogdan Pasaniuc

Excited to come back to Boston in April to discuss health care disparities with a focus on AI.

Join National Cancer Institute for an #AI4CancerResearch conversation on March 26 at 11:00 am ET! Bill Lotter Dana-Farber Data Science, Julian Hong UCSF Helen Diller Family Comprehensive Cancer Ctr, & Leah Zullig, PhD Duke Department of Population Health Sciences will discuss model validation to clinical workflows with #ML in cancer care delivery. events.cancer.gov/nci/cancer-ai-…

Join us for the 2024 Marvin Zelen Symposium one week from today! Each year we invite Boston's data science community for a themed symposium. This year the topic is Health Disparities and Cancer. Drop-ins welcome but spots are limited. Reserve yours here: app.smartsheet.com/b/form/2d650a4…

Minipileup, a straightforward pileup-based multi-sample variant caller. Useful for data inspection or when mainstream callers are not applicable. Initially developed in 2012 as part of htsbox. Now released in a separate repo: github.com/lh3/minipileup

We're pleased to announce lorenzo trippa's promotion to Professor, Dana-Farber & Harvard Biostatistics . Dr. Trippa is an expert in developing and using statistical approaches to accelerate new discoveries in #cancer treatment. ds.dfci.harvard.edu/lorenzo-trippa…

Just published for today's #AACR24 Plenary Session: #ArtificialIntelligence in Oncology— Current Landscape, Challenges, and Future Directions, a review by Ethan Cerami et al. bit.ly/3TWeXUT Dana-Farber Dana-Farber Data Science